|
|
Article: Video: FDA States Consumers Should Continue to Use alli.
- Article from:
- PR Newswire
- Article date:
- September 2, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PARSIPPANY, N.J., Sept. 2 /PRNewswire/ -- The following is an updated GlaxoSmithKline Consumer Healthcare statement in response to the FDA's Early Communication about the safety review of orlistat:
On August 24th the FDA reported that it is continuing its safety review of orlistat and liver-related serious adverse events.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/alli/39949/
It's important consumers know that alli is safe and effective and there's no evidence to suggest alli causes liver injury. In fact, the FDA has said that consumers should continue to use alli as directed.
Because orlistat is ...